hookworms

  • Open Access
    Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans
    Editor's Pick Experimental Therapeutics
    Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans

    Gastrointestinal nematodes (GINs) of humans, e.g., hookworms, negatively impact childhood growth, cognition, nutrition, educational attainment, income, productivity, and pregnancy. Hundreds of millions of people are targeted with mass drug administration (MDA) of donated benzimidazole anthelmintics.

    Hanchen Li, Ambily Abraham, David Gazzola, Yan Hu, Gillian Beamer, Kelly Flanagan, Ernesto Soto, Florentina Rus, Zeynep Mirza, Austin Draper, Sridhar Vakalapudi, Cheryl Stockman, Perry Bain, Joseph F. Urban, Gary R. Ostroff, Raffi V. Aroian
Back to top